5 Oversold NASDAQ Stocks To Buy Right Now

In this article, we will be taking a look at 5 oversold NASDAQ stocks to buy right now. To read our detailed analysis of current stock market news, you can go directly to see the 11 Oversold NASDAQ Stocks To Buy Right Now.

5. Extreme Networks, Inc. (NASDAQ:EXTR)

Number of Hedge Fund Holders: 36

14-day RSI as of March 13: 28.13

Extreme Networks, Inc. (NASDAQ:EXTR) is a communications equipment company based in Morrisville, North Carolina. The company provides software-driven networking solutions worldwide.

As of February 1, Needham analysts maintain a Buy rating and a $16.5 price target on Extreme Networks, Inc. (NASDAQ:EXTR).

In total, 36 hedge funds were long Extreme Networks, Inc. (NASDAQ:EXTR) in the fourth quarter, with a total stake value of $276.2 million.

Fred Alger Management mentioned Extreme Networks, Inc. (NASDAQ:EXTR) in its fourth-quarter 2023 investor letter:

“Extreme Networks, Inc. (NASDAQ:EXTR) specializes in comprehensive, cloud-native networking solutions, combining the design and production of network infrastructure equipment with its exclusive cloud management platform and a wide range of applications. We consider their Wi-Fi and switching equipment and software to be among the top choices for enterprises, managed efficiently over the cloud. Their latest offering, universal equipment, now integrates computing, security, and Al capabilities directly at the enterprise level. This expands their Total Addressable Market (TAM) significantly. During the quarter, the company reported strong fiscal first quarter results, where revenues beat analyst estimates, resulting in margin expansion and higher than expected free cash flow generation. However, management lowered their fiscal full year revenue guidance, citing macroeconomic weakness as enterprises continue to delay network upgrades. As a result, shares detracted from performance.”

4. Immunocore Holdings plc (NASDAQ:IMCR)

Number of Hedge Fund Holders: 22

14-day RSI as of March 13: 27.79

HC Wainwright & Co. analysts maintained a Buy rating and a $90 price target on Immunocore Holdings plc (NASDAQ:IMCR) on March 6.

Based in Abingdon, United Kingdom, Immunocore Holdings plc (NASDAQ:IMCR) is a commercial-stage biotech company. It develops immunotherapies to treat cancer and infectious and autoimmune diseases.

Immunocore Holdings plc (NASDAQ:IMCR) had 22 hedge funds long its stock in the fourth quarter, with a total stake value of $624.6 million.

3. The Bancorp, Inc. (NASDAQ:TBBK)

Number of Hedge Fund Holders: 23

14-day RSI as of March 13: 27.71

Our hedge fund data shows that in the fourth quarter, 23 hedge funds were long The Bancorp, Inc. (NASDAQ:TBBK), with a total stake value of $84.1 million.

The Bancorp, Inc. (NASDAQ:TBBK) is a regional banking company. It is the holding company of The Bancorp Bank, National Association, which provides banking products and services in the US.

An Outperform rating and a $52 price target were maintained on The Bancorp, Inc. (NASDAQ:TBBK) by analysts at Keefe, Bruyette & Woods on March 8.

2. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Number of Hedge Fund Holders: 33

14-day RSI as of March 13: 27.4

Citigroup analysts maintained a Buy rating and a $30.19 price target on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on March 12.

There were 33 hedge funds long ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) in the fourth quarter, with a total stake value of $1.9 billion.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a biotech company. It develops innovative medicines for central nervous system disorders and rare diseases.

1. AN2 Therapeutics Inc. (NASDAQ:ANTX)

Number of Hedge Fund Holders: 17

14-day RSI as of March 13: 15.38

AN2 Therapeutics Inc. (NASDAQ:ANTX) is a pharmaceutical company. It develops treatments for rare, chronic, and serious infectious diseases.

In the fourth quarter, 17 hedge funds were long AN2 Therapeutics Inc. (NASDAQ:ANTX), with a total stake value of $252.1 million.

A Market Perform rating and a $7 price target were placed on AN2 Therapeutics Inc. (NASDAQ:ANTX) on February 13 by analysts at Leerink Partners.

See also 15 Best NASDAQ Dividend Stocks To Buy and 13 Best NASDAQ Penny Stocks To Invest In.